NEW YORK, Aug. 14, 2017 /PRNewswire/ -- This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed.
Read the full report: http://www.reportlinker.com/p05048420/The-Worldwide-Market-for-Liquid-Biopsy.html
Companies covered Include:
cfDNA-based Liquid Biopsy
Adaptive Biotechnologies
Biodesix
Epigenomics
Foundation Medicine
Genomic Health
Guardant Health
Myriad Genetics
Pathway Genomics
Personal Genome Diagnostics
Qiagen
Roche Diagnostics
Sysmex-Inostics
Trovagene
In Development Projects
Adaptive Biotechnologies
Biocartis
Epigenomics
Exact Sciences
Foundation Medicine
Genomic Health
GRAIL
Inivata
Natera
CTC-based Liquid Biopsy
Biocept
Cynvenio Biosystems
Epic Sciences
GILUPI
Menarini-Silicon Biosystems
Qiagen
Angle
Biocept
Epic Sciences
Janssen Diagnostics
Extracellular Vesicles-based Liquid Biopsy
Biodesix
Exosome Diagnostics
Gensignia
Hologic
The report contains:
Market Sizing
Market Forecasts to 2021
Products in Development
Trends and Issues
Company Profiles
Market Segmentation (Analyte, Purpose, Cancer Type)
Overview of Technologies
Read the full report: http://www.reportlinker.com/p05048420/The-Worldwide-Market-for-Liquid-Biopsy.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article